Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Xarelto (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-6 of 6
» View ky3.com items only
    Apr 29, 2013 |Story| Los Angeles Times

  1. FDA approves a drug to reverse anticoagulation

    Ever since the drug warfarin was discovered to be a highly effective anti-clotting agent as well as a good rat poison in the early 1950s, it has been the frontline weapon in preventing stroke among those with atrial fibrillation. But its growing use has always raised the specter of dangerously hard-to-stanch bleeding if someone taking it is wounded or bleeds internally from a fall or a car accident.
    Ever since the drug warfarin was discovered to be a highly effective anti-clotting agent as well as a good rat poison in the early 1950s, it has been the frontline weapon in preventing stroke among those with atrial fibrillation. But its growing use has...

    Tags: Warfarin (drug), Vitamin K, Pradaxa (drug), Rivaroxaban (drug), Physical Conditions

    2. Apr 27, 2013 |Story| McClatchy-Tribune

  2. Phelps ready to fight

    South Bend Tribune, Ind.
    Cancer didn't stand a chance the first time it bothered Digger Phelps three years ago, and the former Notre Dame men's basketball coach has no desire to let it hang around for an extended stay this time. Disclosing late Thursday that he has bladder...

    Tags: Prostate Cancer, Colon Cancer, Medical Procedures and Tests, ESPN (tv network), Vaccines

    3. Apr 25, 2013 |Story| Reuters

  3. ACTUALIZA 1-Bayer reduce perspectiva de plásticos, mayores costos golpean resultados

    Reuters
    (Actualiza con detalles; cambia redacción) FRANCFORT, 25 abr (Reuters) - La débil demanda de plásticos y productos químicos de Bayer obligó al grupo diversificado a reducir sus previsiones para su división MaterialScience, eclipsando las mayores...
    4. Apr 24, 2013 |Story| Reuters

  4. Boehringer anti-clotting pill gains blockbuster status

    Reuters
    INGELHEIM, Germany, April 24 (Reuters) - Boehringer Ingelheim said its anti-blood-clotting drug Pradaxa reached blockbuster status in 2012, helping the world's largest unlisted drugmaker to an 11.5 percent rise in sales for last year. Sales of the pill,...

    Tags: Pradaxa (drug), Johnson & Johnson Inc., Drugs and Medicines, Diabetes, Germany

    5. Nov 12, 2012 |Story| Reuters

  5. Cost becomes bigger question in treating heart disease

    LOS ANGELES (Reuters) - The cost of treating heart disease has become a key factor in decisions by U.S. cardiologists grappling with the nation's No. 1 killer.
    Reuters
    LOS ANGELES (Reuters) - The cost of treating heart disease has become a key factor in decisions by U.S. cardiologists grappling with the nation's No. 1 killer. Record prices for drugs and devices, reduced reimbursement by insurance plans and the...

    Tags: Harvard Medical School, Health Care Reform (2009), Diabetes, Heart Surgery, Barack Obama

    6. Jun 21, 2012 |Story| WSBT-TV

  6. FDA denies expanded approval of J&J blood thinner

    WASHINGTON (AP) — Federal regulators have denied Johnson & Johnson's request to expand approval of its blood thinner Xarelto (ZAR-el-toh) for a new use to prevent life-threatening blood clots in high-risk patients. J&J said Thursday the Food and...

    Tags: Health, Washington, DC, Economy, Business and Finance, Drugs and Medicines, Food and Drug Administration

Original site for Xarelto (drug) topic gallery.